Image: motorolka, via Shutterstock
Further clarity is needed around evidence generation and regulatory expertise, consultancy says
The Dutch government has been advised to scrutinise elements of the EU’s proposed new pharmaceuticals legislation, to ensure that it best supports innovation while offering maximum benefits to patients.
Put forward by the European Commission in 2023, the proposals aim to make EU regulations on new medical treatments more streamlined and efficient, better able to support innovation, and supportive of treatments being rolled out quickly across Europe.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.